Quarterly report pursuant to sections 13 or 15(d)

STOCK OPTIONS AND WARRANTS (Details)

v2.4.0.6
STOCK OPTIONS AND WARRANTS (Details) (USD $)
9 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 9 Months Ended 12 Months Ended
Nov. 13, 2007
Nov. 01, 2004
Mar. 04, 2001
Mar. 31, 2013
Stock Options [Member]
Mar. 31, 2012
Stock Options [Member]
Jun. 30, 2009
Stock Options [Member]
Jun. 30, 2008
Stock Options [Member]
Jun. 30, 2009
Stock Options [Member]
Board Members [Member]
Jun. 30, 2008
Stock Options [Member]
Board Members [Member]
Dec. 20, 2006
Stock Options [Member]
Board Members, Management Employees and Consultants [Member]
Jun. 30, 2009
Stock Options [Member]
Board Members, Management Employees and Consultants [Member]
Jun. 30, 2008
Stock Options [Member]
Board Members, Management Employees and Consultants [Member]
Jun. 30, 2007
Stock Options [Member]
Board Members, Management Employees and Consultants [Member]
Sep. 25, 2007
Non-qualified Stock Options [Member]
Chief Executive Officer [Member]
Aug. 06, 2007
Non-qualified Stock Options [Member]
Chief Executive Officer [Member]
Jun. 30, 2007
Restricted Common Stock [Member]
Board Members [Member]
Jun. 30, 2008
Restricted Common Stock [Member]
Consultants [Member]
Mar. 31, 2013
Warrants [Member]
Mar. 31, 2012
Warrants [Member]
Jun. 30, 2009
Warrants [Member]
Consultants [Member]
Jun. 30, 2008
Warrants [Member]
Consultants [Member]
Jun. 30, 2009
Warrants [Member]
Board Members, Management Employees and Consultants [Member]
Jun. 30, 2008
Warrants [Member]
Board Members, Management Employees and Consultants [Member]
Jun. 30, 2007
Warrants [Member]
Board Members, Management Employees and Consultants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                                
Number of shares authorized (in shares) 6,000,000 4,000,000 3,000,000                                          
Number of shares vested on grant date (in shares)               115,428 464,102                     99,977 240,302      
Number of remaining shares vesting after date of grant (in shares)           566,357 871,000                         148,587 465,000      
Options, weighted average exercise price (in dollars per share)                   $ 1.05 $ 0.77 $ 0.20 $ 0.42 $ 0.74 $ 0.75                  
Options, weighted average grant date fair value (in dollars per share)                   $ 0.69 $ 0.48 $ 0.19 $ 0.32   $ 0.46                  
Warrants, weighted average exercise price (in dollars per share)                                           $ 0.77 $ 0.20  
Warrants, weighted average grant date fair value (in dollars per share)                                           $ 0.48 $ 0.19  
Term of equity-based payment award                   5 years 5 years 5 years 5 years   6 years             5 years 5 years 5 years
Shares granted (in shares)                               148,571 60,000 0 0 248,564 705,302      
Summary of options [Roll Forward]                                                
Outstanding at beginning of period (in shares)       4,341,115 4,797,270                                      
Granted (in shares)       0 0     115,428 464,102 790,770 681,785 1,335,102 1,074,666 1,452,167 484,056                  
Forfeited (in shares)       (861,153)                                        
Expired (in shares)       (257,145) (456,155)                                      
Outstanding at end of period (in shares)       3,222,817 4,341,115                                      
Exercisable at end of period (in shares)       3,222,817 4,341,115                                      
Available for issuance at end of period (in shares)       0 0                                      
Options, weighted-average exercise price [Roll Forward]                                                
Outstanding at beginning of period (in dollars per share)       $ 0.57 $ 0.57                                      
Forfeited (in dollars per share)       $ 0.60                                        
Expired (in dollars per share)       $ 0.60 $ 1.05                                      
Outstanding at end of period (in dollars per share)       $ 0.60 $ 0.59                                      
Non-option equity instruments, number of shares [ Roll Forward]                                                
Outstanding at beginning of period (in shares)                                   958,299 974,920          
Granted (in shares)                                     10,714          
Expired (in shares)                                     (26,351)          
Outstanding at end of period (in shares)                                   958,299 959,283          
Exercisable at end of period (in shares)                                   958,299 959,283          
Equity instruments other than options, weighted-average exercise price [Roll Forward]                                                
Outstanding at beginning of period (in dollars per share)                                   $ 0.46 $ 0.47          
Granted (in dollars per share)                                     $ 0.02          
Expired (in dollars per share)                                     $ 1.02          
Outstanding at end of period (in dollars per share)                                   $ 0.36 $ 0.45